Earnings Call Summary | NovaBay Pharmaceuticals(NBY.US) Q2 2024 Earnings Conference
NovaBay GAAP EPS of -$1.37 Misses by $0.14, Revenue of $2.4M Misses by $0.75M
NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q2 Revenue $2.4M, Vs. Street Est of $3.2M
Express News | NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
Press Release: NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
NovaBay 2Q Loss $1.59M >NBY
NovaBay 2Q Loss/Shr $1.37 >NBY
Here's the Major Earnings After the Close Today
NovaBay Q2 2024 Earnings Preview
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
Express News | NovaBay Pharmaceuticals Inc - From July 16-17, 2024 Period, Avenova Sales Were 17% Higher Compared With Prime Day 2023
Express News | NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
What's Going On With NovaBay Pharmaceuticals (NBY) Stock?
Express News | NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Top Midday Decliners
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
No Data
No Data